HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ — China
Sky One Medical, Inc. (“China Sky One Medical” or “the Company”)
(Nasdaq: CSKI), a leading fully integrated pharmaceutical
company producing over-the-counter drugs in the People’s Republic of China (“PRC”),
today announced that Mr. Stanley
Hao, the Company’s Chief Financial Officer, will participate
in the following investor conferences in May
2010.
CCG China Rising Investment Conference
Time: Monday, May 17, 2010
Presentation: 4:00 pm ET
Location: Grand Hyatt New York, 109 East 42nd Street, New York
Brean Murray, Carret & Co. 2010 Life Sciences Summit
Time: Monday, May 17, 2010
Location: Grand Hyatt New York, 109 East 42nd Street, New York
Oppenheimer China Dragon Call Conference
Time: May 18, 2010
Presentation: 10:00 am ET
Location: 300 Madison Avenue, 3rd Floor, New York
Management will be available for one-on-one meetings with
investors at the conferences. Please contact the respective
representatives for each conference to set up the meetings.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding
company. The Company engages in the manufacturing, marketing and
distribution of pharmaceutical, medicinal and diagnostic products.
Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical
Science and Technology Company (“TDR”), Harbin First
Bio-Engineering Company Limited (“First
‘/>”/>
SOURCE
